Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies

ObjectiveThis study aims to assess the diagnostic efficacy of a combined approach integrating chromosomal karyotyping, copy number variation sequencing (CNV-seq), and quantitative fluorescence polymerase chain reaction (QF-PCR) in detecting chromosomal abnormalities in high-risk pregnancies.MethodsT...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia-pei Liu, Shan-Bing Wang, Li Luo, Ya-mei Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1517270/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543692131762176
author Jia-pei Liu
Shan-Bing Wang
Li Luo
Ya-mei Guo
author_facet Jia-pei Liu
Shan-Bing Wang
Li Luo
Ya-mei Guo
author_sort Jia-pei Liu
collection DOAJ
description ObjectiveThis study aims to assess the diagnostic efficacy of a combined approach integrating chromosomal karyotyping, copy number variation sequencing (CNV-seq), and quantitative fluorescence polymerase chain reaction (QF-PCR) in detecting chromosomal abnormalities in high-risk pregnancies.MethodsThis retrospective study analyzed 617 high-risk pregnancies undergoing prenatal diagnosis from February 2023 to August 2024, with amniotic fluid samples concurrently analyzed using karyotyping, CNV-seq, and QF-PCR. We evaluated clinical characteristics, diagnostic yields, and inter-method concordance rates. Longitudinal follow-up assessed pregnancy outcomes and neonatal phenotypes, with particular emphasis on cases demonstrating diagnostic discrepancies or variants of uncertain clinical significance.ResultsThe integrated approach detected chromosomal abnormalities in 12.5% (77/617) of cases, significantly higher than the rates achieved by karyotyping alone (9.7%) and CNV-seq/QF-PCR alone (8.3%) (p < 0.05). Karyotyping showed full concordance with CNV-seq and QF-PCR in detecting major chromosomal aneuploidies, identifying 21 cases of trisomy 21 and 4 cases of trisomy 18. CNV-seq uniquely identified additional pathogenic copy number variations in 2.1% of cases and variants of uncertain significance (VUS) in 3.2% of cases, both undetectable by conventional karyotyping. Subjects with high-risk non-invasive prenatal testing (NIPT) results had the highest abnormality detection rate (57.6%, p < 0.05). Follow-up data revealed pregnancy termination in 44 of 97 cases with chromosomal abnormalities. Notably, neonates carrying pathogenic CNVs inherited from asymptomatic parents demonstrated normal phenotypes.ConclusionThe integration of karyotyping, CNV-seq, and QF-PCR provides superior diagnostic yield compared to individual testing strategies in high-risk pregnancies. Although karyotyping remains the gold standard for detecting major chromosomal aberrations, CNV-seq and QF-PCR enhance diagnostic precision through detection of submicroscopic variations. Multi-center studies with larger cohorts are needed to confirm these findings and clarify the clinical significance of uncertain variants.
format Article
id doaj-art-5cc1a1b6efce4c1d9fd454e52610a03a
institution Kabale University
issn 1664-8021
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-5cc1a1b6efce4c1d9fd454e52610a03a2025-01-13T06:11:49ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-01-011510.3389/fgene.2024.15172701517270Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnanciesJia-pei Liu0Shan-Bing Wang1Li Luo2Ya-mei Guo3Department of Laboratory, The Second People’s Hospital of Yibin City, Yibin, Sichuan, ChinaDepartment of Oncology Medicine, The Second People’s Hospital of Yibin City, Yibin, Sichuan, ChinaDepartment of Laboratory, The Second People’s Hospital of Yibin City, Yibin, Sichuan, ChinaDepartment of Laboratory, The Second People’s Hospital of Yibin City, Yibin, Sichuan, ChinaObjectiveThis study aims to assess the diagnostic efficacy of a combined approach integrating chromosomal karyotyping, copy number variation sequencing (CNV-seq), and quantitative fluorescence polymerase chain reaction (QF-PCR) in detecting chromosomal abnormalities in high-risk pregnancies.MethodsThis retrospective study analyzed 617 high-risk pregnancies undergoing prenatal diagnosis from February 2023 to August 2024, with amniotic fluid samples concurrently analyzed using karyotyping, CNV-seq, and QF-PCR. We evaluated clinical characteristics, diagnostic yields, and inter-method concordance rates. Longitudinal follow-up assessed pregnancy outcomes and neonatal phenotypes, with particular emphasis on cases demonstrating diagnostic discrepancies or variants of uncertain clinical significance.ResultsThe integrated approach detected chromosomal abnormalities in 12.5% (77/617) of cases, significantly higher than the rates achieved by karyotyping alone (9.7%) and CNV-seq/QF-PCR alone (8.3%) (p < 0.05). Karyotyping showed full concordance with CNV-seq and QF-PCR in detecting major chromosomal aneuploidies, identifying 21 cases of trisomy 21 and 4 cases of trisomy 18. CNV-seq uniquely identified additional pathogenic copy number variations in 2.1% of cases and variants of uncertain significance (VUS) in 3.2% of cases, both undetectable by conventional karyotyping. Subjects with high-risk non-invasive prenatal testing (NIPT) results had the highest abnormality detection rate (57.6%, p < 0.05). Follow-up data revealed pregnancy termination in 44 of 97 cases with chromosomal abnormalities. Notably, neonates carrying pathogenic CNVs inherited from asymptomatic parents demonstrated normal phenotypes.ConclusionThe integration of karyotyping, CNV-seq, and QF-PCR provides superior diagnostic yield compared to individual testing strategies in high-risk pregnancies. Although karyotyping remains the gold standard for detecting major chromosomal aberrations, CNV-seq and QF-PCR enhance diagnostic precision through detection of submicroscopic variations. Multi-center studies with larger cohorts are needed to confirm these findings and clarify the clinical significance of uncertain variants.https://www.frontiersin.org/articles/10.3389/fgene.2024.1517270/fullchromosomal abnormalitiesprenatal diagnosiskaryotypingCNV-seqQF-PCRhigh-risk pregnancy
spellingShingle Jia-pei Liu
Shan-Bing Wang
Li Luo
Ya-mei Guo
Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
Frontiers in Genetics
chromosomal abnormalities
prenatal diagnosis
karyotyping
CNV-seq
QF-PCR
high-risk pregnancy
title Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
title_full Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
title_fullStr Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
title_full_unstemmed Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
title_short Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
title_sort improving prenatal diagnosis with combined karyotyping cnv seq and qf pcr a comprehensive analysis of chromosomal abnormalities in high risk pregnancies
topic chromosomal abnormalities
prenatal diagnosis
karyotyping
CNV-seq
QF-PCR
high-risk pregnancy
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1517270/full
work_keys_str_mv AT jiapeiliu improvingprenataldiagnosiswithcombinedkaryotypingcnvseqandqfpcracomprehensiveanalysisofchromosomalabnormalitiesinhighriskpregnancies
AT shanbingwang improvingprenataldiagnosiswithcombinedkaryotypingcnvseqandqfpcracomprehensiveanalysisofchromosomalabnormalitiesinhighriskpregnancies
AT liluo improvingprenataldiagnosiswithcombinedkaryotypingcnvseqandqfpcracomprehensiveanalysisofchromosomalabnormalitiesinhighriskpregnancies
AT yameiguo improvingprenataldiagnosiswithcombinedkaryotypingcnvseqandqfpcracomprehensiveanalysisofchromosomalabnormalitiesinhighriskpregnancies